BRCA2 carriers with male breast cancer show elevated tumour methylation.

BMC Cancer · 2017 · PMC5594583 · PMID 28893223

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

[ 9 ] found that a highly methylated MBC subgroup was more proliferative and showed a trend towards worse patient outcome.

also in 53,322 other papers

a strong trendno p-value reported

Hypermethylation of FOXC1 (HR:2.3, 95% CI:0.99–8.1, p = 0.053) showed a strong trend towards worse DSS; hypermethylation of other genes showed no prognostic information.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.